PCGF2 and breast cancer: In addition, previous studies have also shown that MEL-18 loss causes aggressive phenotypes in breast cancer, such as facilitating stem cell activity, angiogenesis, cell cycle progression, and EMT (Figure 4E) [31,128,129,243].